Do Vegetarians Live Longer?January 2006
By William Faloon
Don’t Overeat Beef
Excess consumption of red meat is linked to a number of age-related disorders, especially atherosclerosis. The author of the recent study linking carnosine deficiency to higher glycation rates in vegetarians concedes that red meat’s detrimental health effects may outweigh the anti-glycation benefits conferred by the carnosine that is naturally present in meat.
Health-conscious consumers often minimize their consumption of meat, thus depriving their bodies of carnosine. If carnosine is the missing link in explaining why vegetarians do not live that much longer than omnivores, then supplementation with 1000 mg a day of carnosine would appear to be at least as important as vitamin B12 for those on meat-restricted diets.
How We Protect You
The long-term goal of Life Extension research is to develop effective therapies to control aging, combat age-related disease, and eradicate death itself. A more immediate objective is to identify compounds that Foundation members can use today to live longer and healthier lives.
For instance, when our research showed that vegetarians were not living that much longer than meat eaters, we needed to find out why. After reviewing hundreds of scientific papers, we identified published research showing that vegetarians are lacking carnosine and that this deficiency could have lethal consequences.
Life Extension long ago identified carnosine’s unique and critical anti-aging properties. So when we saw that vegetarians are devoid of carnosine and that low dietary intakes of carnosine provide virtually no benefit, it became clear that health-conscious individuals who avoid meat are unintentionally causing excess glycation to occur in their bodies, thereby accelerating age-related disease. No other organization on this planet goes to the extreme lengths that we do to identify and then neutralize the biological culprits that cause premature disease and death.
We currently support research at five separate laboratories employing 30 scientific personnel. We also conduct in-house human clinical studies in order to ascertain whether dietary supplements are as effective as their manufacturers claim them to be. Many of the supplements we test do not meet the efficacy claims made by their manufacturers. Supplements that fail our clinical studies are not offered or recommended to members.
In this month’s issue, we describe scientific research funded this year by the Life Extension Foundation. One of our most significant findings was validating that resveratrol may indeed slow the aging process.
Back in August 2003, research from Harvard University showed that resveratrol extended the life span of yeast by 70%.83 What caused so much excitement about this particular study was that resveratrol activated a “longevity gene” expressed during caloric restriction. Since caloric restriction dramatically extends maximum life span in mammals, scientists stated that humans might be able to derive some of the benefits of caloric restriction by taking a resveratrol pill.
Life Extension tested resveratrol and other nutrients used by members and found results that help corroborate the successful yeast studies. We used our proprietary gene-assay technology to demonstrate that resveratrol (and other nutrients) mimic many of the genetic changes seen in calorie-restricted mice. As a Life Extension member, you will find out information about resveratrol in this month’s issue before it is published in a scientific journal.
For longer life,
1. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol. 2005 Jan;25(1):3-8.
2. Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9.
3. Wunsch-Filho V. The epidemiology of oral and pharynx cancer in Brazil. Oral Oncol. 2002 Dec;38(8):737-46.
4. Nothlings U, Wilkens LR, Murphy SP, et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst. 2005 Oct 5;97(19):1458-65.
5. Sinha R, Peters U, Cross AJ, et al. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res. 2005 Sep 1;65(17):8034-41.
6. Correa Lima MP, Gomes-da-Silva MH. Colorectal cancer: lifestyle and dietary factors. Nutr Hosp. 2005 Jul;20(4):235-41.
7. Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005 Jun 15;97(12):906-16.
8. Walker M, Aronson KJ, King W, et al. Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer. 2005 Sep 10;116(4):592-8.
9. Chang ET, Smedby KE, Zhang SM, et al. Dietary factors and risk of non-Hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):512-20.
10. Satia JA, Keku T, Galanko JA, et al. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):429-36.
11. Chao A, Thun MJ, Connell CJ, et al. Meat consumption and risk of colorectal cancer. JAMA. 2005 Jan 12;293(2):172-82.
12. Gunter MJ, Probst-Hensch NM, Cortessis VK et al. Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study. Carcinogenesis. 2005 Mar;26(3):637-42.
13. Larsson SC, Rafter J, Holmberg L, Bergkvist L, Wolk A. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer. 2005 Feb 20;113(5):829-34.
14. English DR, MacInnis RJ, Hodge AM, et al. Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1509-14.
15. Appleby P, Thorogood M, McPherson K, Mann J. Emergency appendicectomy and meat consumption in the UK. J Epidemiol Community Health. 1995 Dec;49(6):594-6.
16. Schulze MB, Hoffmann K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005 Sep;82(3):675-84.
17. Seaman DR. The diet-induced proinflammatory state: a cause of chronic pain and other degenerative diseases? J Manipulative Physiol Ther. 2002 Mar;25(3):168-79.
18. Grant WB. The role of meat in the expression of rheumatoid arthritis. Br J Nutr. 2000 Nov;84(5):589-95.
19. De Stefani E, Fierro L, Mendilaharsu M, et al. Meat intake, ‘mate’ drinking and renal cell cancer in Uruguay: a case-control study. Br J Cancer. 1998 Nov;78(9):1239-43.
20. Soroka N, Silverberg D, Greemland M, et al. Comparison of vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998;79(2):173-80.
21. McDougall J, Litzau K, Haver E, Saunders V, Spiller GA. Rapid reduction of serum cholesterol and blood pressure by a twelve-day, very low fat, strictly vegetarian diet. J Am Coll Nutr. 1995 Oct;14(5):491-6.
22. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol. 1997 Feb;26(1):1-13.
23. Sabate J. The contribution of vegetarian diets to human health. Forum Nutr. 2003;56:218-20.
24. Kwok TK, Woo J, Ho S, Sham A. Vegetarianism and ischemic heart disease in older Chinese women. J Am Coll Nutr. 2000 Oct;19(5):622-7.
25. Key TJ, Fraser GE, Thorogood M, et al. Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr. 1999 Sep;70(3 Suppl):516S-24S.
26. Rimm EB, Ascherio A, Giovannucci E, et al. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996 Feb 14;275(6):447-51.
27. Fraser GE. A comparison of first event coronary heart disease rates in two contrasting California populations. J Nutr Health Aging. 2005;9(1):53-8.
28. Key TJ, Thorogood M, Appleby PN, Burr ML. Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ. 1996 Sep 28;313(7060):775-9.
29. Thorogood M, Mann J, Appleby P, McPherson K. Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters. BMJ. 1994 Jun 25;308(6945):1667-70.
30. Esselstyn CB, Jr., Ellis SG, Medendorp SV, Crowe TD. A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice. J Fam Pract. 1995 Dec;41(6):560-8.
31. Available at: www.nytimes.com/specials/ women/warchive/971120_1599.html. Accessed October 5, 2005.
32. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995 Jun;61(6 Suppl):1360S-7S.
33. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease. The lipid research clinics coronary primary prevention trial and follow-up study. JAMA. 1994 Nov 9;272(18):1439-41.
34. Gaziano JM, Manson JE, Branch LG, et al. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol. 1995 Jul;5(4):255-60.
35. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993 Oct 23;342(8878):1007-11.
36. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med. 1999 Oct 11;159(18):2170-4.
37. Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001 Jun 19;134(12):1106-114.
38. Key TJ, Fraser GE, Thorogood M, et al. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr. 1998 Mar;1(1):33-41.
39. Singh PN, Sabate J, Fraser GE. Does low meat consumption increase life expectancy in humans? Am J Clin Nutr. 2003 Sep;78(3 Suppl):526S-32S.
40. Fraser GE, Shavlik DJ. Ten years of life: Is it a matter of choice? Arch Intern Med. 2001 Jul 9;161(13):1645-52.
41. Hipkiss AR. Glycation, ageing and carnosine: Are carnivorous diets beneficial? Mech Ageing Dev. 2005 Oct;126(10):1034-9.
42. Wu JT. Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications. J Clin Lab Anal. 1993;7(5):293-300.
43. Ahmed N. Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005 Jan;67(1):3-21.
44. Asif M, Egan J, Vasan S, et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA. 2000 Mar 14;97(6):2809-13.
45. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003 Jan;21(1):3-12.
46. Zieman S, Kass D. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail. 2004 May;10(3):144-9.
47. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol. 1993 Feb 25;71(6):26B-31B.
48. Franke S, Dawczynski J, Strobel J, et al. Increased levels of advanced glycation end products in human cataractous lenses. J Cataract Refract Surg. 2003 May;29(5):998-1004.
49. Pokupec R, Kalauz M, Turk N, Turk Z. Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses. Graefes Arch Clin Exp Ophthalmol. 2003 May;241(5):378-84.
50. Taguchi A, Blood DC, del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000 May 18;405(6784):354-60.
51. Bhawal UK, Ozaki Y, Nishimura M, et al. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology. 2005;69(3):246-55.
52. Takada M, Hirata K, Ajiki T, Suzuki Y, Kuroda Y. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology. 2004 Jul;51(58):928-30.
53. Kuniyasu H, Chihara Y, Takahashi T. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep. 2003 Mar;10(2):445-8.
54. Kuniyasu H, Oue N, Wakikawa A, et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol. 2002 Feb;196(2):163-70.
55. Takeuchi M, Kikuchi S, Sasaki N, et al. Involvement of advanced glycation end-products (AGEs) in Alzheimer’s disease. Curr Alzheimer Res. 2004 Feb;1(1):39-46.
56. Yan SD, Stern D, Kane MD, et al. RAGE-Abeta interactions in the pathophysiology of Alzheimer’s disease. Restor Neurol Neurosci. 1998 Jun;12(2-3):167-73.
57. Thome J, Kornhuber J, Munch G, et al. New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs). Nervenarzt. 1996 Nov;67(11):924-9.
58. Krajcovicova-Kudlackova M, Sebekova K, Schinzel R, Klvanova J. Advanced glycation end products and nutrition. Physiol Res. 2002;51(3):313-6.
59. Sebekova K, Krajcovicova-Kudlackova M, Schinzel R, et al. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur J Nutr. 2001 Dec;40(6):275-81.
60. Park YJ, Volpe SL, Decker EA. Quantitation of carnosine in humans plasma after dietary consumption of beef. J Agric Food Chem. 2005 Jun 15;53(12):4736-9.
61. Available at: www.lef.org/magazine/ mag2001/jan2001_report_carnosine_1.html. Accessed October 5, 2005.
62. Quinn PJ, Boldyrev AA, Formazuyk VE. Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med. 1992;13(5):379-444.
63. Stadtman ER. Protein oxidation and aging. Science. 1992 Aug 28;257(5074):1220-4.
64. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res. 1998 Mar;37(3):586-600.
65. Munch G, Schinzel R, Loske C, et al. Alzheimer’s disease—synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm. 1998;105(4-5):439-61.
66. Hipkiss AR, Michaelis J, Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross- linking agent. FEBS Lett. 1995 Aug 28;371(1):81-5.
67. Munch G, Mayer S, Michaelis J, et al. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acta. 1997 Feb 27;1360(1):17-29.
68. Hipkiss AR, Chana H. Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem Biophys Res Commun. 1998 Jul 9;248(1):28-32.
69. Wang AM, Ma C, Xie ZH, Shen F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry (Mosc.). 2000 Jul;65(7):869-71.
70. Brownson C, Hipkiss AR. Carnosine reacts with a glycated protein. Free Radic Biol Med. 2000 May 15;28(10):1564-70.
71. Hipkiss AR, Preston JE, Himswoth DT, Worthington VC, Abbot NJ. Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci Lett. 1997 Dec 5;238(3):135-8.
72. Yuneva MO, Bulygina ER, Gallant SC, et al. Effect of carnosine on age-induced changes in senescence-accelerated mice. J Anti-Aging Med. 1999;2(4):337-42.
73. Boldyrev AA, Stvolinsky SL, Tyulina OV, et al. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell Mol Neurobiol. 1997 Apr;17(2):259-71.
74. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci. 1998 Jun 11;158(1):47-52.
75. Lee JY, Friedman JE, Angel I, Kozak A, Koh JY. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging. 2004 Nov;25(10):1315-21.
76. Hipkiss AR, Preston JE, Himsworth DT, et al. Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann NY Acad Sci. 1998 Nov 20;854:37-53.
77. McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res. 1994 Jun;212(2):167-75.
78. Hipkiss AR, Michaelis J, Syrris P, et al. Strategies for the extension of human life span. Perspect Hum Biol. 1995;1:59-70.
79. McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Gerontol. 1999 Jan;34(1):35-45.
80. Stuerenburg HJ, Kunze K. Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle biopsies and rat muscles. Arch Gerontol Geriatr. 1999 Sep;29(2):107-13.
81. Burcham PC, Kerr PG, Fontaine F. The antihypertensive hydralazine is an efficient scavenger of acrolein. Redox Rep. 2000;5(1):47-9.
82. Zaloga GP, Roberts PR, Black KW, et al. Carnosine is a novel peptide modulator of intracellular calcium and contractility in cardiac cells. Am J Physiol. 1997 Jan;272(1 Pt 2):H462-8.
83. Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003 Sep 11;425(6954):191-6.